image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Our latest issue will be released in 9 days, don't miss out!

Hunting

March 2024

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • HTG
  • Price:
  • 297.5p
After two months deliberating, I finally added Hunting to TP2 last month, my confidence boosted by a trading update which not only reconfirmed existing expectations (EBITDA: US$96m-US$100m), powered by EBITDA margins rising from 7% to c. 10.5% but also said margins are on track to hit its 2025 target of c. 14-16%. In addition, EBITDA for 2024 is expected to hit US$125m-US$135m, bang in line. But the “new” news is the 12% growth in its sales order book from the end of Q3 to c. US$575m (and +21% year-on-year) following a further large order win for titanium stress joints and OCTG accessories for clients in the Black Sea and South America, respectively. Helped by strong collections and the completion of residual oil &am ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author